🇺🇸 FDA

Company profile · Sponsor

Xijing

Xijing Hospital of Digestive Diseases

C121CA4 · NMPA pharma CN
Pipeline
2
Drugs
0
Patents
0

Quick answer

Xijing (C121CA4) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C121CA4
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (2)

Search pipeline →

  1. Fenofibrate

    Xijing

    Primary Biliary Cirrhosis

    phase 3 small molecule active

    1 trial

  2. Metformin

    Xijing

    Gastric Intestinal Metaplasia

    approved small molecule completed

    1 trial

Frequently asked questions

What is Xijing?

Xijing (C121CA4) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Xijing sponsor?

We track 2 ClinicalTrials.gov-linked programs for Xijing, including Fenofibrate and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Xijing company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.